Patients Sue Genzyme Over Fabrazyme Rationing
A group of patients slapped Genzyme Corp. with a putative national class action in Pennsylvania on Wednesday over the rationing plan it implemented for its enzyme replacement drug Fabrazyme after safety...To view the full article, register now.
Already a subscriber? Click here to view full article